Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ananth M. Anthes"'
Publikováno v:
The Annals of pharmacotherapy. 55(5)
Background Accurate monitoring of intravenous unfractionated heparin (UFH) is essential to mitigate the risk of adverse drug events associated with dosing errors. Although recent data support anti-factor Xa (anti-Xa) monitoring preferentially over ac
Publikováno v:
Critical Care Medicine. 49:416-416
Autor:
Amy L. Seybert, Pamela L. Smithburger, Michael J Armahizer, Sandra L. Kane-Gill, Ananth M. Anthes
Publikováno v:
ISRN Critical Care. 2013:1-6
Purpose. The purpose of this project was to compare DDI severity for clinician opinion in the context of the patient’s clinical status to the severity of proprietary databases. Methods. This was a single-center, prospective evaluation of DDIs at a
Autor:
Ananth M. Anthes, Sandra L. Kane-Gill, Pamela L. Smithburger, Amy L. Seybert, Lisa M. Harinstein
Publikováno v:
Pharmacoepidemiology and Drug Safety. 22:510-516
Purpose This study aimed to determine the frequency and type of adverse drug events (ADEs) identified in intensive care unit (ICU) transfer summaries and in the hospital discharge summaries to demonstrate the effectiveness of ICU transfer summary sur
Autor:
Ty A. Ridenour, Ananth M. Anthes, Neal Benedict, Shoroq M. Altawalbeh, Sandra L. Kane-Gill, Matthew Felbinger
Publikováno v:
Critical Care Medicine. 40:1-328
Autor:
Shoroq M. Altawalbeh, Matthew Felbinger, Sandra L. Kane-Gill, Neal Benedict, Ananth M. Anthes, Ty A. Ridenour
Publikováno v:
Journal of critical care. 29(6)
Purpose Patient-reported outcomes (PROs) are recommended as indicators of quality in the intensive care unit. We studied the correlation between PROs of sedation quality and a universal sedation assessment scale in critically ill patients. Materials
Autor:
Ananth M. Anthes, ra L. Kane-Gill, Amy L. Seybert, Pamela L. Smithburger, Michael J Armahizer
Publikováno v:
Advances in Pharmacoepidemiology and Drug Safety.
Purpose: Commercial clinical decision support software (CDSS) may overestimate the severity of drug-drug interactions (DDI) because of their broad application; whereas, clinicians with knowledge of the patient should be able to better assess DDI seve
Autor:
Ananth M. Anthes
Publikováno v:
Critical Care Medicine. 41:A300